Literature DB >> 27018934

Resource Utilization for Noncardiac Admissions in Pediatric Patients With Single Ventricle Disease.

Ian D Thomas1, Michael D Seckeler2.   

Abstract

Patients with single ventricle (SV) congenital heart disease (CHD) incur high hospital costs during staged surgical palliation. Health care resource utilization for noncardiac admissions in patients with SV has not been reported. This study sought to compare costs and outcomes for common noncardiac hospital admissions between patients with SV and patients without CHD. Hospital discharge data from the University Health System Consortium from January 2011 to December 2013 was queried for patients aged ≤18 years with International Classification of Diseases, Ninth Revision (ICD-9) codes for SV lesions: hypoplastic left heart syndrome (746.7), tricuspid atresia (746.1), or common ventricle (745.3). Primary diagnosis, direct cost, length of stay (LOS), intensive care unit admission rate and mortality data were obtained. The 10 most common noncardiac admission diagnoses were compared between patients with SV and patients without CHD using t test and Fisher's exact test. Total direct cost, LOS, and intensive care unit admission rate were higher for patients with SV for all diagnoses with the exception of LOS for dehydration, which was not different between groups. Hospital mortality was significantly higher for patients with SV admitted for acute kidney injury, esophageal reflux, failure to thrive, respiratory syncytial virus bronchiolitis and pneumonia. In conclusion, our study demonstrates that patients with SV CHD admitted with noncardiac diagnoses have higher health care resource utilization compared to those without CHD. As long-term survival increases, it can be expected that this patient group will use a disproportionate amount of medical dollars. Further characterization of costs will be important so steps can be taken to reduce or prevent hospitalization in these patients.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27018934     DOI: 10.1016/j.amjcard.2016.02.043

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Risk Factors for Heart Failure and Its Costs Among Children with Complex Congenital Heart Disease in a Medicaid Cohort.

Authors:  Deipanjan Nandi; Joseph W Rossano; Yinding Wang; Jeanette M Jerrell
Journal:  Pediatr Cardiol       Date:  2017-08-29       Impact factor: 1.655

2.  Resource Utilization for Prenatally Diagnosed Single-Ventricle Cardiac Defects: A Philadelphia Fetus-to-Fontan Cohort Study.

Authors:  Benjamin Zielonka; Brian S Snarr; Michael Y Liu; Xuemei Zhang; Christopher E Mascio; Stephanie Fuller; J William Gaynor; Thomas L Spray; Jack Rychik
Journal:  J Am Heart Assoc       Date:  2019-05-29       Impact factor: 5.501

Review 3.  Advances in Managing Transition to Adulthood for Adolescents With Congenital Heart Disease: A Practical Approach to Transition Program Design: A Scientific Statement From the American Heart Association.

Authors:  Anitha S John; Jamie L Jackson; Philip Moons; Karen Uzark; Andrew S Mackie; Susan Timmins; Keila N Lopez; Adrienne H Kovacs; Michelle Gurvitz
Journal:  J Am Heart Assoc       Date:  2022-03-17       Impact factor: 6.106

4.  Analysis of Vocal Fold Motion Impairment in Neonates Undergoing Congenital Heart Surgery.

Authors:  Stephanie E Ambrose; Julina Ongkasuwan; Kavita Dedhia; Gillian R Diercks; Samantha Anne; Subhadra Shashidharan; Nikhila Raol
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-05-01       Impact factor: 6.223

5.  Congenital heart disease and the cost of mortality.

Authors:  Richard J Czosek; Jeffery B Anderson
Journal:  Open Heart       Date:  2016-05-23

6.  Status of Comorbid Congenital Anomalies and Their Influence on Resource Use in Pediatric Inpatients: A Serial Cross-Sectional Study in Shanghai, China.

Authors:  Jianwei Shi; Ning Chen; Wenya Yu; Rui Liu; Hua Jin; Zhaohu Yu; Li Luo; Li Gu; Rong Yang; Qian Liu; Wei Feng; Zhaoxin Wang
Journal:  Front Public Health       Date:  2020-10-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.